| Published Application/Species/Sample/Dilution | Reference |
|---|
- other; mouse; loading ...; fig 4g
| Zheng D, Gao F, Cheng Q, Bao P, Dong X, Fan J, et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy. Nat Commun. 2020;11:1985 pubmed publisher |
- blocking or activating experiments; mouse; loading ...; fig 5
| Webb L, Lundie R, Borger J, Brown S, Connor L, Cartwright A, et al. Type I interferon is required for T helper (Th) 2 induction by dendritic cells. EMBO J. 2017;36:2404-2418 pubmed publisher |
| Hickerson B, Sefing E, Bailey K, Van Wettere A, Penichet M, Gowen B. Type I interferon underlies severe disease associated with Junín virus infection in mice. elife. 2020;9: pubmed publisher |
| Ma H, Qian W, Bambousková M, Collins P, Porter S, Byrum A, et al. Barrier-to-Autointegration Factor 1 Protects against a Basal cGAS-STING Response. MBio. 2020;11: pubmed publisher |
| Li X, Liu Z, Zhang A, Han C, Shen A, Jiang L, et al. NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance. Nat Commun. 2019;10:3251 pubmed publisher |
| Barnstorf I, Borsa M, Baumann N, Pallmer K, Yermanos A, Joller N, et al. Chronic virus infection compromises memory bystander T cell function in an IL-6/STAT1-dependent manner. J Exp Med. 2019;216:571-586 pubmed publisher |
| Wang A, Pope S, Weinstein J, Yu S, Zhang C, Booth C, et al. Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice. Proc Natl Acad Sci U S A. 2019;116:2200-2209 pubmed publisher |
| Bullard B, Corder B, Gorman M, Diamond M, Weaver E. Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine. Sci Rep. 2018;8:18017 pubmed publisher |
| Xin G, Zander R, Schauder D, Chen Y, Weinstein J, Drobyski W, et al. Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection. Nat Commun. 2018;9:5037 pubmed publisher |
| Athmer J, Fehr A, Grunewald M, Qu W, Wheeler D, Graepel K, et al. Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses. MBio. 2018;9: pubmed publisher |
| Macal M, Jo Y, Dallari S, Chang A, Dai J, Swaminathan S, et al. Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection. Immunity. 2018;48:730-744.e5 pubmed publisher |
| Takeda Y, Azuma M, Funami K, Shime H, Matsumoto M, Seya T. Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide. Front Immunol. 2018;9:496 pubmed publisher |
| Zamarin D, Ricca J, Sadekova S, Oseledchyk A, Yu Y, Blumenschein W, et al. PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy. J Clin Invest. 2018;128:1413-1428 pubmed publisher |
| Hamilton J, Wu Q, Yang P, Luo B, Liu S, Hong H, et al. Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells. J Immunol. 2017;199:2618-2623 pubmed publisher |
| Gibb D, Liu J, Santhanakrishnan M, Natarajan P, Madrid D, Patel S, et al. B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice. Transfusion. 2017;57:2595-2608 pubmed publisher |
| Shinde P, Liu W, Menoret A, Luster A, Vella A. Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production. J Leukoc Biol. 2017;102:57-69 pubmed publisher |
| Pepini T, Pulichino A, Carsillo T, Carlson A, Sari Sarraf F, Ramsauer K, et al. Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design. J Immunol. 2017;198:4012-4024 pubmed publisher |
| Xin Q, Deng C, Chen X, Wang J, Wang S, Wang W, et al. Quantitative Proteomic Analysis of Mosquito C6/36 Cells Reveals Host Proteins Involved in Zika Virus Infection. J Virol. 2017;91: pubmed publisher |
| Connor L, Tang S, Cognard E, Ochiai S, Hilligan K, Old S, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125-142 pubmed publisher |
| Li M, Bozzacco L, Hoffmann H, Breton G, Loschko J, Xiao J, et al. Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion. J Exp Med. 2016;213:2931-2947 pubmed |
| Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier W, et al. CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med. 2015;21:1209-15 pubmed publisher |
| Welten S, Redeker A, Franken K, Oduro J, Ossendorp F, ÄŒiÄin Å ain L, et al. The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion. elife. 2015;4: pubmed publisher |
| Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, et al. STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells. Cancer Res. 2015;75:3812-22 pubmed publisher |
| Schliehe C, Flynn E, Vilagos B, Richson U, Swaminanthan S, Bosnjak B, et al. The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection. Nat Immunol. 2015;16:67-74 pubmed publisher |
| Ma Y, Bramwell K, Lochhead R, Paquette J, Zachary J, Weis J, et al. Borrelia burgdorferi arthritis-associated locus Bbaa1 regulates Lyme arthritis and K/B×N serum transfer arthritis through intrinsic control of type I IFN production. J Immunol. 2014;193:6050-60 pubmed publisher |
| Calame D, Mueller Ortiz S, Morales J, Wetsel R. The C5a anaphylatoxin receptor (C5aR1) protects against Listeria monocytogenes infection by inhibiting type 1 IFN expression. J Immunol. 2014;193:5099-107 pubmed publisher |
| Stock A, Smith J, Carbone F. Type I IFN suppresses Cxcr2 driven neutrophil recruitment into the sensory ganglia during viral infection. J Exp Med. 2014;211:751-9 pubmed publisher |
| Beug S, Tang V, LaCasse E, Cheung H, Beauregard C, Brun J, et al. Smac mimetics and innate immune stimuli synergize to promote tumor death. Nat Biotechnol. 2014;32:182-90 pubmed publisher |
